Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | METAP2 | P50579 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.31 |
| ▸ | GSR | P00390 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21453531 | 0.93 | CYP1A2 (0.32) | CYP1A2METAP2ALOX12EGLN1GSR | |
| SCHEMBL21008745 | 0.90 | HTT (0.34) | CYP1A2METAP2EGLN1GSR | |
| SCHEMBL21008712 | 0.89 | MDM2 (0.34) | CYP1A2METAP2ALOX12GSR | |
| SCHEMBL21008882 | 0.88 | EGLN1 (0.33) | CYP1A2METAP2ALOX12EGLN1GSR | |
| SCHEMBL21008750 | 0.87 | CYP1A2 (0.30) | CYP1A2METAP2 | |
| SCHEMBL21008925 | 0.85 | — | — | |
| SCHEMBL21008833 | 0.84 | CYP1A2 (0.40) | CYP1A2METAP2ALOX12EGLN1 | |
| SCHEMBL21008904 | 0.81 | CYP1A2 (0.38) | CYP1A2METAP2ALOX12EGLN1 | |
| SCHEMBL21453370 | 0.80 | CYP1A2 (0.32) | CYP1A2METAP2ALOX12GSR | |
| SCHEMBL21008839 | 0.79 | KDM4E (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190148647-A1 | NITROGEN-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190148647-A1 | NITROGEN-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | CRY2, NUCB2, NOX1 | CYP1A2 805/4885METAP2 1773/4885ALOX12 1930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.